Table 4.
Change in HbA1c levels by group.
| Measurement time point | Intervention group | Control group | |||||
|
|
|
n | Mean % (SD or 95% CI) | Total value (mmol/mol) |
n | Mean % (SD or 95% CI) | Total value (mmol/mol) |
| HbA1c included in t test (n=97) |
|
|
|
|
|
|
|
|
|
Baseline, mean (SD) | 48 | 8.69 (1.32) | 71.5 | 49 | 8.89 (1.30) | 73.7 |
|
|
6 months, mean (SD) | 48 | 7.88 (1.17) | 62.6 | 49 | 8.13 (1.27) | 65.4 |
|
|
Change from baseline to 6 months, mean (95% CI) | 48 | 0.82 (0.46-1.17)a | 8.9 | 49 | 0.76 (0.41-1.11)a | 8.3 |
| HbA1c included in ANOVA b (n=89) |
|
|
|
|
|
|
|
|
|
Baseline, mean (SD) | 45 | 8.60 (1.19) | 70.5 | 44 | 8.88 (1.32) | 73.6 |
|
|
3 months, mean (SD) | 45 | 7.74 (1.06) | 61.1 | 44 | 8.26 (1.16) | 66.8 |
|
|
6 months, mean (SD) | 45 | 7.76 (1.00) | 61.3 | 44 | 8.07 (1.29) | 64.7 |
|
|
Change from baseline to 3 months, mean (95% CI) | 45 | 0.86 (0.47-1.26)a | 9.4 | 44 | 0.62 (0.23-1.03)a | 6.8 |
|
|
Change from baseline to 6 months, mean (95% CI) | 45 | 0.84 (0.38-1.26)a | 9.2 | 44 | 0.81 (0.34-1.28)a | 8.9 |
aSignificant at the P=.001 level.
bAnalysis of variance (ANOVA).